Literature DB >> 8726229

Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats.

R S Clark1, P M Kochanek, M A Schwarz, J K Schiding, D S Turner, M Chen, T M Carlos, S C Watkins.   

Abstract

The inflammatory response after traumatic brain injury (TBI) includes cytokine production, leukocyte infiltration, and microglial activation. Production of nitric oxide by inducible nitric oxide synthase (iNOS) occurs during acute inflammation outside of the CNS and in models of cerebral ischemia, and therefore may contribute to the inflammatory response after TBI. The purpose of this study was to localize and define the time course of iNOS expression after TBI in the immature rat. Immature Wistar rats (age 3.5-4.5 wk) were anesthetized and subjected to percussive trauma to the right parietal cortex. Nontraumatized rats were used as controls (n = 7). At 2, 24, 48, or 168 h (n = 3/group) posttrauma rats were killed by perfusion fixation. Brains were removed, frozen, sectioned, immunostained with antibodies against iNOS and glial fibrillary acidic protein (GFAP, a marker specific for astrocytes), and imaged using fluorescent detection systems. There was no detectable expression of iNOS in control brains. At 2h, minimal cerebrovascular iNOS expression was seen in the peritrauma area. At 24 and 48 h, there was marked peritrauma cerebrovascular iNOS expression that appeared to be restricted to vascular smooth muscle cells and infiltrated leukocytes. Further dual-immunolabeling showed that the leukocytes expressing iNOS were predominantly neutrophils. At 168 h, iNOS expression was no longer detectable. iNOS was not detectable in GFAP-positive cells. The prominent expression of iNOS protein after TBI in cerebrovascular smooth muscle cells and infiltrated neutrophils suggests that iNOS may play a role in cerebrovascular disturbances and secondary brain injury after trauma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726229     DOI: 10.1203/00006450-199605000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  35 in total

1.  Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury.

Authors:  Aniv Mann; Reem Smoum; Victoria Trembovler; Alexander Alexandrovich; Aviva Breuer; Raphael Mechoulam; Esther Shohami
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-27       Impact factor: 4.147

Review 2.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Alterations in default-mode network connectivity may be influenced by cerebrovascular changes within 1 week of sports related concussion in college varsity athletes: a pilot study.

Authors:  Adam R Militana; Manus J Donahue; Allen K Sills; Gary S Solomon; Andrew J Gregory; Megan K Strother; Victoria L Morgan
Journal:  Brain Imaging Behav       Date:  2016-06       Impact factor: 3.978

Review 4.  Pre-clinical models in pediatric traumatic brain injury-challenges and lessons learned.

Authors:  Patrick M Kochanek; Jessica S Wallisch; Hülya Bayır; Robert S B Clark
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

5.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 6.  Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.

Authors:  Michael G Fehlings; Dung H Nguyen
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

7.  Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.

Authors:  Flaubert Tchantchou; Yumin Zhang
Journal:  J Neurotrauma       Date:  2013-04-05       Impact factor: 5.269

8.  Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

Authors:  C Iadecola; F Zhang; R Casey; M Nagayama; M E Ross
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

9.  Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.

Authors:  Mushfiquddin Khan; Yeong-Bin Im; Anandakumar Shunmugavel; Anne G Gilg; Ramanpreet K Dhindsa; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2009-11-04       Impact factor: 8.322

10.  Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.

Authors:  Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin
Journal:  BMC Neurosci       Date:  2009-08-31       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.